6:54 PM
 | 
Dec 11, 2012
 |  BC Extra  |  Financial News

Theradiag slips in Euronext trading debut

Diagnostics company Theradiag (Euronext:ALTER) was down EUR 0.14 to EUR 5.66 in its first day of trading Tuesday on NYSE Euronext Paris....

Read the full 93 word article

User Sign in

Trial Subscription

Get a 4-week free trial subscription to BioCentury Extra

Article Purchase

$50 USD
More Info >